{"id":1958,"date":"2013-07-16T13:24:30","date_gmt":"2013-07-16T13:24:30","guid":{"rendered":"https:\/\/www.lymphoma.ca\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/"},"modified":"2013-07-16T13:24:30","modified_gmt":"2013-07-16T13:24:30","slug":"une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003","status":"publish","type":"post","link":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/","title":{"rendered":"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003"},"content":{"rendered":"<p>Selon une \u00e9tude publi\u00e9e r\u00e9cemment par le Dr Daryl Tan et ses coll\u00e8gues de la Stanford University, des progr\u00e8s encourageants ont \u00e9t\u00e9 constat\u00e9s en mati\u00e8re de survie globale des patients atteints<br \/>\n<!--more--><\/p>\n<p>Selon une \u00e9tude publi\u00e9e r\u00e9cemment par le Dr Daryl Tan et ses coll\u00e8gues de la Stanford University, des progr\u00e8s encourageants ont \u00e9t\u00e9 constat\u00e9s en mati\u00e8re de survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2, et ce, \u00e0 tous les stades de la progression de la maladie. Entre 1960 et 2003, 1 334 patients ont particip\u00e9 \u00e0 l\u2019\u00e9tude et re\u00e7u des traitements au Stanford University Medical Center. Cette p\u00e9riode a \u00e9t\u00e9 divis\u00e9e en quatre phases, chacune \u00e9tant consacr\u00e9e \u00e0 des traitements sp\u00e9cifiques.<\/p>\n<ul>\n<li>Phase 1 : avant les anthracyclines (1960-1975)<\/li>\n<li>Phase 2 : anthracyclines (1976-1986)<\/li>\n<li>Phase 3 : chimioth\u00e9rapie agressive\/ antipurines (1987-1996)<\/li>\n<li>Phase 4 : rituximab (1997-2003)<\/li>\n<\/ul>\n<p>La survie globale (SG) des patients a \u00e9t\u00e9 calcul\u00e9e \u00e0 partir de la date du diagnostic jusqu\u2019\u00e0 la date de d\u00e9c\u00e8s, quelle qu\u2019en soit la cause, et elle a \u00e9t\u00e9 d\u00e9termin\u00e9e durant chaque phase de traitement. La SG a augment\u00e9, passant de 11 ans dans la Phase 1 et la Phase 2, \u00e0 18,5 ans dans la Phase 3. Bien que la SG de la Phase 4 n\u2019ait pas encore \u00e9t\u00e9 \u00e9tablie, aucun plateau n\u2019a \u00e9t\u00e9 observ\u00e9, et il est donc fort probable que la tendance positive en mati\u00e8re d\u2019am\u00e9lioration de la SG se poursuivra. Il existe plusieurs autres r\u00e9sultats encourageants issus de cette \u00e9tude. Le taux de survie globale \u00e0 10 ans a \u00e9galement augment\u00e9, passant de 54 % dans les Phases 1 et 2, \u00e0 68 % dans la Phase 3, et \u00e0 73 % dans la Phase 4. En outre, l\u2019\u00e9tude a permis de constater une am\u00e9lioration de la SG tant au stade pr\u00e9coce de la maladie (1-2) qu\u2019\u00e0 son stade ultime (3-4) chez les patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2.<\/p>\n<p>Cette augmentation du taux de survie globale est probablement attribuable aux progr\u00e8s r\u00e9alis\u00e9s en mati\u00e8re de traitements et de soins de soutien. En plus d\u2019\u00eatre extr\u00eamement encourageants, ces r\u00e9sultats illustrent que les progr\u00e8s accomplis dans la r\u00e9alisation des traitements actuels ont des effets positifs et am\u00e9liorent le taux de survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2.<\/p>\n<hr \/>\n<h6>Tan, D., Horning, S. J., Hoppe, R. T., Levy, R., Rosenberg, S. A., Sigal, B. M., et al. (2013). <em>Improvements in observed and relative survival in follicular grade 1-2 lymphoma over four decades: the Stanford University experience<\/em>. <em>Blood<\/em>, Diffusion en ligne avant l\u2019impression. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=23777769\">http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=23777769<\/a><\/h6>\n","protected":false},"excerpt":{"rendered":"<p>Selon une \u00e9tude publi\u00e9e r\u00e9cemment par le Dr Daryl Tan et ses coll\u00e8gues de la Stanford University, des progr\u00e8s encourageants ont \u00e9t\u00e9 constat\u00e9s en mati\u00e8re de survie globale des patients&#8230;<\/p>\n","protected":false},"author":1,"featured_media":1771,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17],"tags":[],"class_list":{"0":"post-1958","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-recherche"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003 - Lymphoma Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003 - Lymphoma Canada\" \/>\n<meta property=\"og:description\" content=\"Selon une \u00e9tude publi\u00e9e r\u00e9cemment par le Dr Daryl Tan et ses coll\u00e8gues de la Stanford University, des progr\u00e8s encourageants ont \u00e9t\u00e9 constat\u00e9s en mati\u00e8re de survie globale des patients...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/\" \/>\n<meta property=\"og:site_name\" content=\"Lymphoma Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LymphomaCanada\" \/>\n<meta property=\"article:published_time\" content=\"2013-07-16T13:24:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:site\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\"},\"headline\":\"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003\",\"datePublished\":\"2013-07-16T13:24:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/\"},\"wordCount\":471,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"articleSection\":[\"Recherche\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/\",\"name\":\"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003 - Lymphoma Canada\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"datePublished\":\"2013-07-16T13:24:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#primaryimage\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"width\":700,\"height\":300,\"caption\":\"masthead_ph_shadows\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lymphoma.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"name\":\"Lymphoma Canada\",\"description\":\"Information. Help. Hope.\",\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\",\"name\":\"Lymphoma Canada\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"width\":343,\"height\":343,\"caption\":\"Lymphoma Canada\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LymphomaCanada\",\"https:\/\/x.com\/lymphomacanada\",\"https:\/\/www.linkedin.com\/company\/lymphoma-canada\/\",\"http:\/\/instagram.com\/lymphomacanada\",\"http:\/\/www.youtube.com\/user\/LymphomaTV\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003 - Lymphoma Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/","og_locale":"fr_FR","og_type":"article","og_title":"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003 - Lymphoma Canada","og_description":"Selon une \u00e9tude publi\u00e9e r\u00e9cemment par le Dr Daryl Tan et ses coll\u00e8gues de la Stanford University, des progr\u00e8s encourageants ont \u00e9t\u00e9 constat\u00e9s en mati\u00e8re de survie globale des patients...","og_url":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/","og_site_name":"Lymphoma Canada","article_publisher":"https:\/\/www.facebook.com\/LymphomaCanada","article_published_time":"2013-07-16T13:24:30+00:00","og_image":[{"width":700,"height":300,"url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@lymphomacanada","twitter_site":"@lymphomacanada","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#article","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/"},"author":{"name":"admin","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4"},"headline":"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003","datePublished":"2013-07-16T13:24:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/"},"wordCount":471,"commentCount":0,"publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","articleSection":["Recherche"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/","url":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/","name":"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003 - Lymphoma Canada","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#primaryimage"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","datePublished":"2013-07-16T13:24:30+00:00","breadcrumb":{"@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#primaryimage","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","width":700,"height":300,"caption":"masthead_ph_shadows"},{"@type":"BreadcrumbList","@id":"https:\/\/www.lymphoma.ca\/fr\/une-etude-de-la-stanford-university-demontre-une-amelioration-de-la-survie-globale-des-patients-atteints-dun-lymphome-folliculaire-de-grade-1-et-de-grade-2-entre-1960-et-2003\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lymphoma.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Une \u00e9tude de la Stanford University d\u00e9montre une am\u00e9lioration de la survie globale des patients atteints d\u2019un lymphome folliculaire de grade 1 et de grade 2 entre 1960 et 2003"}]},{"@type":"WebSite","@id":"https:\/\/www.lymphoma.ca\/fr\/#website","url":"https:\/\/www.lymphoma.ca\/fr\/","name":"Lymphoma Canada","description":"Information. Help. Hope.","publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.lymphoma.ca\/fr\/#organization","name":"Lymphoma Canada","url":"https:\/\/www.lymphoma.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","width":343,"height":343,"caption":"Lymphoma Canada"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LymphomaCanada","https:\/\/x.com\/lymphomacanada","https:\/\/www.linkedin.com\/company\/lymphoma-canada\/","http:\/\/instagram.com\/lymphomacanada","http:\/\/www.youtube.com\/user\/LymphomaTV"]},{"@type":"Person","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/1958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/comments?post=1958"}],"version-history":[{"count":0,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/1958\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media\/1771"}],"wp:attachment":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media?parent=1958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/categories?post=1958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/tags?post=1958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}